Delivery Order SPE2DB20D1100-SPE2DB22FD1F5
Award Date
8/23/22
Potential Completion Date
8/24/22
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Gadavist 7.5 mmol/7.5 ml vial. The firm-fixed-price contract has a ceiling value of $2,957.51 and is set to expire on April 26, 2024. This order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $3,377.44 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Gadavist 10 mmol/10 ml vial 10 ml. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Gadavist 10 MMOL/10 ML vials. The award, valued at $4,315.48, is a Firm Fixed Price Delivery Order with a completion date of June 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $6,796.40 firm-fixed-price contract is for the supply of 10 milliliter vials of the pharmaceutical product Gadavist, with a performance period through August 15, 2024. AmerisourceBergen is a large pharmaceutical distributor that provides a wide range of medical commodities to various government agencies and healthcare programs, including the military. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,164.96 firm fixed price delivery order is for the supply of the pharmaceutical product Gadavist 7.5 mmol/7.5 ml vial, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award is for the supply of the pharmaceutical product Gadavist (7.5 mmol/7.5 ml vial, 7.5 ml) to the Defense Logistics Agency (DLA). The $1,071.13 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The Defense Logistics Agency awarded a $1,711.35 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 30ml GADAVIST 1 MMOL/ML bulk vial pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The contract has a firm fixed price of $1,704.90 and an ultimate completion date of March 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of GADAVIST 1 MMOL/ML BULK VIAL 30ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,711.35 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of July 2, 2024 and was awarded on July 1, 2024. There was no set-aside designation used for this award. Amerisourcebergen holds a larger...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ94V, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,729.46 firm fixed-price delivery order is for the pharmaceutical product Gadavist 10 mmol/10 ml vial 10 ml. The award has an ultimate completion date of January 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...